Received Aug 5, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MNQ | MENINGOCOCCAL CONJUGATE (MENVEO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | E4A39 | — |
patient received today (29-Jul-2025) a dose of the Menveo (1 vial) that expires on 30-Jun-2025; This non-serious case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a 16-year-old male patient who received Men ACWY-CRM NVS (Menveo) (batch number E4A39, expiry date 30-JUN-2025) for prophylaxis. On 29-JUL-2025, the patient received Menveo. On 29-JUL-2025, an unknown time after receiving Menveo, the patient experienced expired vaccine used (Verbatim: patient received today (29-Jul-2025) a dose of the Menveo (1 vial) that expires on 30-Jun-2025). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 29-JUL-2025 The clinic coordinator reported that a patient received an expired dose of the Menveo (1 vial), which led to expired vaccine used The HCP asked for recommendations on this situation.